The U.S. Food and Drug Administration is getting tough on clinics marketing stem cell “therapies” that are unproven and potentially dangerous.
The U.S. Food and Drug Administration is getting tough on clinics marketing stem cell “therapies” that are unproven and potentially dangerous.